What is the 13F Pro Quality Score for TMO?

13F Pro ranks THERMO FISHER SCIENTIFIC INC. (TMO) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View TMO's current score at https://13fpro.ai/company/TMO (free sign-up required for the full ranking).

Which hedge funds own the most TMO stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of TMO include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/TMO as soon as new 13F filings post.

Where does 13F Pro source TMO data?

All THERMO FISHER SCIENTIFIC INC. fundamentals and ownership data come directly from SEC EDGAR. THERMO FISHER SCIENTIFIC INC. files with the SEC under CIK 97745. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is TMO in?

THERMO FISHER SCIENTIFIC INC. (TMO) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

What drives TMO's revenue?

Per THERMO FISHER SCIENTIFIC INC.'s latest 10-Q filed with the SEC on 2026-07-31, the biggest revenue drivers are: Laboratory Products and Biopharma Services ($6,652M, +12% YoY); Clinical research ($2,396M); Life Sciences Solutions ($2,355M, +13% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/TMO.

What are TMO's largest expenses?

THERMO FISHER SCIENTIFIC INC.'s latest 10-Q reports these as the largest expense items: Cost of service revenues ($3,650M); Cost of product revenues ($3,462M); Selling, general and administrative expenses ($2,333M). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 27, 2026).

How often is TMO research updated on 13F Pro?

TMO's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

THERMO FISHER SCIENTIFIC INC.(TMO)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →NYSEmega

Institutional-grade research for retail investors

SEC EDGAR: CIK 97745 TMO stock profile & AI dashboard →

13F Pro Quality Score

65.1/100

Rank #500 of 2,961 stocksTOP 25%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

41.1/100

Profitability

73.1/100

Balance Sheet

75.7/100

Earnings Quality

49.0/100

Free Cash Flow

66.3/100

Institutional Flow

60.3/100

Revenue Scale

96.7/100

Dilution Risk

67.3/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why TMO Scores 65/100

exact factor attribution · 2026-09-11

TMO's composite is driven by scale and profitability, held back by revenue growth. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+7.0 pts

97th pct

Profitability

+3.5 pts

73th pct

Capital efficiency

+2.6 pts

76th pct

Free cash flow

+2.4 pts

66th pct

Shareholder dilution

+0.9 pts

67th pct

Institutional flow

+0.5 pts

60th pct

Earnings growth

+0.1 pts

53th pct

Earnings quality

-0.1 pts

49th pct

Revenue growth

-1.8 pts

41th pct

Latest change (2026-07-31): 64 → 66 · ↑ Free cash flow 62→75

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

TMO Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for THERMO FISHER SCIENTIFIC INC. (TMO), a Technology sector company. 13F Pro's AI-powered ranking engine scores TMO at 65.1/100 on a 32-signal composite quality model, placing it at rank #500 of 2,961 stocks — the top 25% of the AI-ranked universe. TMO scores in the top quartile across revenue scale (96.7), balance sheet strength (75.7). Based on the latest XBRL financial filings (Q2 2026), THERMO FISHER SCIENTIFIC INC. reports quarterly revenue of $12.0B, net income of $1.7B, an operating margin of 17.4%. Top institutional holders of TMO by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. TMO trades on the NYSE exchange and files with the SEC under CIK 97745. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TMO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for THERMO FISHER SCIENTIFIC INC. directly from SEC EDGAR. THERMO FISHER SCIENTIFIC INC.'s 13F Pro composite quality score has ranged between 57 and 76 since 2021, currently 65.1 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

What's Driving TMO's Business? Latest 10-Q Breakdown

✓ 31/31 datapoints verified

AI-extracted from THERMO FISHER SCIENTIFIC INC.'s 10-Q filed 2026-07-31 — Q2 FY2026 (quarter ended June 27, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Q2 revenue rose 10% to $11.99B, but only 5% organically — acquisitions (chiefly Clario) contributed 5 points — while GAAP operating margin improved to 17.4% from 16.9%.

Biggest Revenue Drivers

Laboratory Products and Biopharma Services$6,652M+12% YoY

Growth in the research and safety market channel and the clinical research business

Life Sciences Solutions$2,355M+13% YoY

Bioproduction grew $196 million on higher pharma and biotech demand plus the 2025 filtration and separation acquisition

Biggest Revenue Drivers

Total revenue: $11,994M+10% YoY

Laboratory Products and Biopharma Services$6,652M+12% YoY

Growth in the research and safety market channel and the clinical research business

Within Laboratory Products and Biopharma Services

Clinical research$2,396M

Grew $441 million, contributing 7 points of segment reported growth, primarily driven by the impact of the Clario acquisition

Life Sciences Solutions$2,355M+13% YoY

Bioproduction grew $196 million on higher pharma and biotech demand plus the 2025 filtration and separation acquisition

Analytical Instruments$1,799M+7% YoY

Growth across all three businesses, led by electron microscopy (+$55 million)

Specialty Diagnostics$1,188M+6% YoY

Driven by the healthcare market channel (+$36 million) and immunodiagnostics business

Largest Expense Items

Cost of service revenues$3,650M

Rose from $3,207M a year ago as service revenues grew to $5,171M

Cost of product revenues$3,462M

Up from $3,239M; company cites productivity improvements from its PPI Business System

Selling, general and administrative expenses$2,333M

Up from $2,140M, reflecting acquisitions and strategic investments in commercial capabilities

Research and development expenses$364M

Up modestly from $352M

Margins: GAAP operating margin rose 0.5 pt to 17.4% and adjusted margin 0.9 pt to 22.8%, due primarily to strong productivity improvements, offset in part by unfavorable business mix.

Watch Items from the Filing

Reported growth of 10% included 5 points from acquisitions and 1 point currency; organic growth was only 5%.
Clario purchase price totaled $9.10B, adding $5,934M goodwill; cash fell from $9.85B to $4.06B and total debt rose to $42.55B.
Net interest expense nearly doubled to $194M from $107M on higher debt for buybacks, dividends and the Clario acquisition.
Additional restructuring charges of approximately $220 million expected, primarily in the Laboratory Products and Biopharma Services segment.
Remaining performance obligations of $29.70 billion, about 52% expected to be recognized within the next twelve months.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$12.0B

Net Income

Q2 2026

$1.7B

Free Cash Flow

Q2 2026

$1.7B

Operating Margin

Q2 2026

17.4%

ROIC

Q2 2026

8.5%

D/E Ratio

Q2 2026

0.87

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+3.9% YoY

$44.56BFY 2025

FY22 $44.91BFY23 $42.86BFY24 $42.88BFY25 $44.56B

Net Income

+5.8% YoY

$6.70BFY 2025

FY22 $6.96BFY23 $6.00BFY24 $6.33BFY25 $6.70B

Operating Income

+5.6% YoY

$7.75BFY 2025

FY22 $8.39BFY23 $6.86BFY24 $7.34BFY25 $7.75B

EPS (Diluted)

+7.3% YoY

$17.74FY 2025

FY22 $17.63FY23 $15.45FY24 $16.53FY25 $17.74

Total Assets

+13.4% YoY

$110.34BFY 2025

FY22 $97.15BFY23 $98.73BFY24 $97.32BFY25 $110.34B

Total Debt

+28.3% YoY

$42.70BFY 2025

FY22 $39.86BFY23 $38.34BFY24 $33.29BFY25 $42.70B

Op. Cash Flow

-9.8% YoY

$7.82BFY 2025

FY22 $9.15BFY23 $8.41BFY24 $8.67BFY25 $7.82B

Free Cash Flow

-13.4% YoY

$6.29BFY 2025

FY22 $6.91BFY23 $6.93BFY24 $7.27BFY25 $6.29B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$44.56B +3.9%	$42.88B +0.1%	$42.86B -4.6%	$44.91B +14.5%	$39.21B +21.7%	$32.22B
Net Income	$6.70B +5.8%	$6.33B +5.7%	$6.00B -13.9%	$6.96B -9.9%	$7.73B	—
Operating Income	$7.75B +5.6%	$7.34B +7.0%	$6.86B -18.3%	$8.39B -16.3%	$10.03B +28.7%	$7.79B
EPS (Diluted)	$17.74 +7.3%	$16.53 +7.0%	$15.45 -12.4%	$17.63 -9.4%	$19.46 +21.9%	$15.96
Total Assets	$110.34B +13.4%	$97.32B -1.4%	$98.73B +1.6%	$97.15B +2.1%	$95.12B +37.8%	$69.05B
Total Debt	$42.70B +28.3%	$33.29B -13.2%	$38.34B -3.8%	$39.86B +7.1%	$37.21B +52.8%	$24.36B
Operating Cash Flow	$7.82B -9.8%	$8.67B +3.1%	$8.41B -8.2%	$9.15B -1.7%	$9.31B +12.3%	$8.29B
Free Cash Flow	$6.29B -13.4%	$7.27B +4.9%	$6.93B +0.2%	$6.91B +1.8%	$6.79B -0.4%	$6.82B

Get alerted when TMO's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for THERMO FISHER SCIENTIFIC INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of TMO

BlackRock, Inc.
$15.5B30,919,632 sh
VANGUARD CAPITAL MANAGEMENT LLC
$12.2B24,276,316 sh
STATE STREET CORP
$8.4B16,825,879 sh
FMR LLC
$7.1B14,084,488 sh
MORGAN STANLEY
$5.4B10,763,066 sh
JPMORGAN CHASE & CO
$4.3B8,503,527 sh
GEODE CAPITAL MANAGEMENT, LLC
$4.2B8,382,401 sh
FRANKLIN RESOURCES INC
$3.6B7,271,514 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$3.1B6,226,169 sh
Capital World Investors
$3.1B6,195,370 sh

Fund	Value	Shares
BlackRock, Inc.	$15.5B	30,919,632
VANGUARD CAPITAL MANAGEMENT LLC	$12.2B	24,276,316
STATE STREET CORP	$8.4B	16,825,879
FMR LLC	$7.1B	14,084,488
MORGAN STANLEY	$5.4B	10,763,066
JPMORGAN CHASE & CO	$4.3B	8,503,527
GEODE CAPITAL MANAGEMENT, LLC	$4.2B	8,382,401
FRANKLIN RESOURCES INC	$3.6B	7,271,514
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.1B	6,226,169
Capital World Investors	$3.1B	6,195,370

Companies Similar to TMO

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

DHR

DANAHER CORP /DE/

AI score

Highly similar · 46 shared holders

Capital Research Global Investors Capital International Investors FLOSSBACH VON STORCH SE

ADP

AUTOMATIC DATA PROCESSING INC

AI score

Very similar · 24 shared holders

Capital Research Global Investors Clearbridge Investments, LLC Ninety One UK Ltd

EMR

EMERSON ELECTRIC CO

AI score

Very similar · 26 shared holders

Swedbank AB 1832 Asset Management L.P.KING LUTHER CAPITAL MANAGEMENT CORP

Trane Technologies plc

AI score

Very similar · 29 shared holders

Capital Research Global Investors Capital International Investors Capital World Investors

TXN

TEXAS INSTRUMENTS INC

AI score

Very similar · 41 shared holders

Capital Research Global Investors Grantham, Mayo, Van Otterloo & Co. LLC PRIMECAP MANAGEMENT CO/CA/

AMAT

APPLIED MATERIALS INC /DE

AI score

Very similar · 31 shared holders

Capital Research Global Investors Capital World Investors Capital International Investors

NOC

NORTHROP GRUMMAN CORP /DE/

AI score

Very similar · 21 shared holders

Capital World Investors Capital International Investors Capital Research Global Investors

ROK

ROCKWELL AUTOMATION, INC

AI score

Very similar · 25 shared holders

Robeco Institutional Asset Management B.V.Alecta Tjanstepension Omsesidigt Quilter Plc

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put TMO on your watchlist

Track score changes the day THERMO FISHER SCIENTIFIC INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is TMO a good stock to buy?

13F Pro's AI-powered analysis of THERMO FISHER SCIENTIFIC INC. (TMO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TMO are available on the TMO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TMO is classified as a mega company.

Which hedge funds own TMO?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TMO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of THERMO FISHER SCIENTIFIC INC.'s investment landscape.